Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUP62 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | POU2F1 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | RBM10 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | BEND3 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | FUBP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | KRI1 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-07 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | P4HA2 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-07 |
mRNA | SRSF4 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |